These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25367596)

  • 41. Prolonged QT interval in neonates: benign, transient, or prolonged risk of sudden death.
    Villain E; Levy M; Kachaner J; Garson A
    Am Heart J; 1992 Jul; 124(1):194-7. PubMed ID: 1352080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors and incidence for lipid abnormalities in kidney transplant patients.
    Ichimaru N; Yamanaka K; Kato T; Kakuta Y; Abe T; Imamura R; Nonomura N; Kaimori JY; Takahara S
    Transplant Proc; 2015 Apr; 47(3):672-4. PubMed ID: 25891708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of index of cardiac-electrophysiological balance before and after hemodialysis in patients with end-stage renal disease.
    Sivri S; Çelik M
    J Electrocardiol; 2019; 54():72-75. PubMed ID: 30928820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients.
    Nakao S; Hatano K; Sumi C; Masuzawa M; Sakamoto S; Ikeda S; Shingu K
    Anesth Analg; 2010 Mar; 110(3):775-9. PubMed ID: 20185656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High QT dispersion in tacrolimus-treated kidney transplant recipients.
    Gerhardt U; Suwelack B; Pawolka A; Hohage H
    Transplant Proc; 2001 May; 33(3):2148-50. PubMed ID: 11377482
    [No Abstract]   [Full Text] [Related]  

  • 46. Paced QT interval is a better predictor of mortality than the intrinsic QT interval: long-term follow-up study.
    Lee JM; Janardhan AH; Kang KW; Joung B; Pak HN; Sundaram S; Choe WC; Lee MH; Hwang HJ
    Heart Rhythm; 2014 Jul; 11(7):1184-9. PubMed ID: 24726972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anorexia nervosa in a pediatric renal transplant recipient and its reversal with cyclosporine.
    Okechuku G; Boulos AK; Herman L; Upadhyay K
    Pediatr Transplant; 2015 May; 19(3):E78-82. PubMed ID: 25661468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic dysfunction in kidney transplant recipients: prevalence and impact on graft and patient survival.
    Gheith OA; Saad MA; Hassan AA; A-Eldeeb S; Agroudy AE; Sheashaa H; Ghoneim MA
    Clin Exp Nephrol; 2007 Dec; 11(4):309-315. PubMed ID: 18085393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine.
    Spagnoletti G; Citterio F; Favi E; Rossi E; Delreno F; De Santis I; Salerno MP; Gargiulo A; Castagneto M
    Transplant Proc; 2009 May; 41(4):1175-7. PubMed ID: 19460509
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetics and nonmelanoma skin cancer in kidney transplant recipients.
    Burke MT; Isbel N; Barraclough KA; Jung JW; Wells JW; Staatz CE
    Pharmacogenomics; 2015 Jan; 16(2):161-72. PubMed ID: 25616102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of exposure to immunosuppressive treatment during pregnancy on renal function and rate of apoptosis in native kidneys of female Wistar rats.
    Kabat-Koperska J; Kolasa-Wołosiuk A; Baranowska-Bosiacka I; Safranow K; Kosik-Bogacka D; Gutowska I; Pilutin A; Gołembiewska E; Kędzierska K; Ciechanowski K
    Apoptosis; 2016 Nov; 21(11):1240-1248. PubMed ID: 27586504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. QT prolongation and sudden cardiac death in patients with alcoholic liver disease.
    Day CP; James OF; Butler TJ; Campbell RW
    Lancet; 1993 Jun; 341(8858):1423-8. PubMed ID: 8099138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Tpeak-Tend interval and Tpeak-end/QT ratio in patients with Sarcoidosis.
    Ucsular F; Karadeniz G; Karadeniz C; Yalnız E; Demir M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):151-6. PubMed ID: 27537718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ventricular repolarization in diabetic patients: characterization and clinical implications.
    Clemente D; Pereira T; Ribeiro S
    Arq Bras Cardiol; 2012 Nov; 99(5):1015-22. PubMed ID: 23108644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients.
    Furth S; Neu A; Colombani P; Plotnick L; Turner ME; Fivush B
    Pediatr Nephrol; 1996 Feb; 10(1):64-6. PubMed ID: 8611359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective evaluation of corrected QT intervals and arrhythmias after exposure to epirubicin, cyclophosphamide, and 5-fluorouracil in women with breast cancer.
    Kitagawa K; Kawada K; Morita S; Inada M; Mitsuma A; Sawaki M; Iino S; Inden Y; Murohara T; Imai T; Ando Y
    Ann Oncol; 2012 Mar; 23(3):743-747. PubMed ID: 21690231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.
    Favi E; Citterio F; Spagnoletti G; Gargiulo A; Delreno F; Romagnoli J; Castagneto M
    Transplant Proc; 2009 May; 41(4):1152-5. PubMed ID: 19460503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of metabolic acidosis on QT intervals in patients with chronic kidney disease.
    Yenigun EC; Aypak C; Turgut D; Aydin MZ; Dede F
    Int J Artif Organs; 2016 Aug; 39(6):272-6. PubMed ID: 27515860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.